Humacyte, Inc. Appoints The Honorable Kathleen Sebelius And Dale A. Sander To Board Of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, Inc., a pioneer in biotechnology and regenerative medicine, announced today that former U.S. Secretary of Health and Human Services, Kathleen Sebelius, and healthcare executive, Dale A. Sander have been elected to the Board of Directors effective September 1, 2015 bringing the size of the Humacyte Board to eight directors.

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.